|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 The Hypertension and Vascular Disease Center, Winston-Salem, NC, USA
* To whom correspondence should be addressed. E-mail: mchappel{at}wfubmc.edu.
We established a new congenic model of hypertension, the mRen(2).Lewis rat and assessed the intracellular expression of angiotensin peptides and receptors in the kidney. The congenic strain was established from the backcross of the (mRen2)27 transgenic rat that expresses the mouse renin 2 gene onto the Lewis strain. The 20 week old male congenic rats were markedly hypertensive as compared to the Lewis controls [systolic blood pressure: 195 ± 2 versus 107 ± 2 mmHg, p < 0.01]. Although plasma Ang II levels were not different between strains, circulating levels of Ang-(1-7) were 270% higher and Ang I concentrations were 40% lower in the mRen2.Lewis rats. In contrast, both cortical (CORT) and medullary (MED) Ang II concentrations were 60% higher in the mRen2.Lewis rats, while tissue Ang I was 66% and 84% lower in CORT and MED. For both strains, MED Ang II, Ang I and Ang-(1-7) were significantly higher than CORT levels. Intracellular Ang II binding distinguished nuclear (NUC) and plasma membrane (PM) receptor using the Ang II radioligand 125I-Sarthran. Isolated CORT nuclei exhibited a high density (Bmax >200 fmol/mg protein) and affinity for the Sarthran ligand (KD<0.5 nM), the majority of these sites (>95%) were the AT1 receptor subtype. CORT Ang II receptor Bmax and KD values in nuclei were 75% and 50% lower, respectively, for the mRen(2).Lewis versus the Lewis rats. In the MED, the PM receptor density [Lewis: 50 ± 4 versus mRen2.Lewis: 21 ± 5 fmol/mg protein) and affinity [KD: Lewis: 0.31 ± 0.1 versus 0.69 ± 0.1 nM] were lower in the mRen2.Lewis. In summary, the hypertensive mRen2.Lewis rats exhibit higher Ang II in both CORT and MED regions of the kidney. Evaluation of intracellular Ang II receptors revealed lower CORT NUC and MED PM AT1 sites in the mRen2.Lewis. The down-regulation of AT1 sites in the mRen2.Lewis may reflect a compensatory response to dampen the elevated levels of intrarenal Ang II.
This article has been cited by other articles:
![]() |
J. A. Jessup, B. M. Westwood, M. C. Chappell, and L. Groban Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat Therapeutic Advances in Cardiovascular Disease, August 1, 2009; 3(4): 245 - 257. [Abstract] [PDF] |
||||
![]() |
E. Gava, A. Samad-Zadeh, J. Zimpelmann, N. Bahramifarid, G. T. Kitten, R. A. Santos, R. M. Touyz, and K. D. Burns Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1766 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Gwathmey, H. A. Shaltout, K. D. Pendergrass, N. T. Pirro, J. P. Figueroa, J. C. Rose, D. I. Diz, and M. C. Chappell Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1484 - F1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Pendergrass, N. T. Pirro, B. M. Westwood, C. M. Ferrario, K. B. Brosnihan, and M. C. Chappell Sex differences in circulating and renal angiotensins of hypertensive mRen(2).Lewis but not normotensive Lewis rats Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H10 - H20. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Yamaleyeva, K. D. Pendergrass, N. T. Pirro, P. E. Gallagher, L. Groban, and M. C. Chappell Ovariectomy is protective against renal injury in the high-salt-fed older mRen2.Lewis rat Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2064 - H2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Zhuo and X. C Li Review: Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 23 - 33. [Abstract] [PDF] |
||||
![]() |
J. A. Jessup, P. E. Gallagher, D. B. Averill, K. B. Brosnihan, E. A. Tallant, M. C. Chappell, and C. M. Ferrario Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2166 - H2172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |